Amylyx Pharmaceuticals (AMLX) Stock Price
$4.61 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
3 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Amylyx Pharmaceuticals, AI stock picks, stock alerts and much more.
AMLX AI Stock Analysis
AI stock analysis for AMLX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Amylyx Pharmaceuticals (AMLX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Amylyx Pharmaceuticals (AMLX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Amylyx Pharmaceuticals (AMLX), currently trading at $4.61, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About AMLX
-
Amylyx Pharmaceuticals, Inc.
-
Symbol
AMLX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
410.7M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$23.37 2.7% |
6 |
 |
Inovio Pharmaceuticals INO |
$1.8 1.1% |
1 |
 |
Moderna MRNA |
$24.25 0.5% |
3 |
 |
Anavex Life Sciences AVXL |
$8.25 3.6% |
5 |
 |
BridgeBio Pharma BBIO |
$34.17 2% |
6 |
News
AMLX Alternative Data
Web Traffic
Amylyx Pharmaceuticals receives an estimated 6367 monthly visitors to amylyx.com, which is down by -6.5% over the last month.
-
Web Traffic
6367
-
Change from Previous Month
6.5%
-
3 Month Change
25.2%
-
YoY Change
25.2%
Reddit Mentions
Amylyx Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Amylyx Pharmaceuticals has 2,937 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.
-
Twitter Followers
2937
-
Daily Change
0.2%
-
1 Month Change
0%
-
3 Month Change
0.2%
Facebook Engagement
Amylyx Pharmaceuticals has engaged 17 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
17
-
Daily Change
29.2%
-
1 Month Change
26.1%
-
3 Month Change
1600%
LinkedIn Followers
70,306 are following Amylyx Pharmaceuticals on LinkedIn, up by 0.4% over the last month.
-
LinkedIn Followers
70306
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.9%
Job Postings
Amylyx Pharmaceuticals currenly has an estimated 6 open job postings, up by 20% over the last month.
-
Job Postings
6
-
Daily Change
0%
-
1 Month Change
20%
-
3 Month Change
20%
LinkedIn Employees
According to LinkedIn, Amylyx Pharmaceuticals has 164 employees, down by -3.5% over the last month.
-
LinkedIn Employees
164
-
Daily Change
0%
-
1 Month Change
3.5%
-
3 Month Change
6.8%
News Mentions
Amylyx Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Amylyx Pharmaceuticals is 52 out of 100 (neutral).
-
Business Outlook
52
-
Change from Previous Month
10.3%
-
3 Month Change
0%
-
YoY Change
0%
AMLX Financials
AMLX Key Metrics
-
Total Revenue
-$665K
-
Net Income
-$37.5M
-
Earnings per Share
-$0.55
-
Free cash flow
-$59M
-
EBITDA
-$40.5M
-
EBITDA Ratio
60.8932
-
Total Assets
$193.6M
AMLX 2-year Revenue & Income
AMLX 2-year Free Cash Flow
AMLX Technicals
AMLX SMA
AMLX RSI
FAQ
What's the current price of Amylyx Pharmaceuticals (AMLX) Stock?
The price of an Amylyx Pharmaceuticals (AMLX) share is $4.61.
What's the market cap of Amylyx Pharmaceuticals?
The current market cap of Amylyx Pharmaceuticals is 410.7M.
Should I buy or sell AMLX?
Amylyx Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Amylyx Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Amylyx Pharmaceuticals a good investment?
The current analysis of Amylyx Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Amylyx Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Amylyx Pharmaceuticals (AMLX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Amylyx Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Amylyx Pharmaceuticals (AMLX) that investors often compare it to?
Amylyx Pharmaceuticals (AMLX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Amylyx Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Amylyx Pharmaceuticals' stock price to be around $4.48 in 2026. Starting from the current price of $4.61, this represents a 2.9% change in price, indicating a neutral outlook for the stock.
How to buy Amylyx Pharmaceuticals (AMLX) Stock?
Amylyx Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Amylyx Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.